Dr. Naveed Janjua
Senior Scientist Hepatitis Program, Clinical Prevention Services, BCCDC and Clinical Assistant Professor, School of Population & Public Health, UBC
Dr. Naveed Zafar Janjua is an epidemiologist and senior scientist with hepatitis program in the clinical prevention services at the BC Centre for Disease Control and Clinical Assistant Professor at School of Population and Public Health, University of British Columbia. Dr. Janjua is a Medical Doctor (MBBS) with a Masters of Science (MSc) degree in Epidemiology & Biostatistics and Doctorate in Public Health (DrPH). At BCCDC, his work involves surveillance, research and policy advice related to hepatitis. His research interest includes hepatitis B and C epidemiology, disparities in treatment access and disease outcomes, influenza epidemiology/immuno-epidemiology, and vaccine effectiveness. His global health research includes unsafe medical injections and transmission of blood borne pathogens, socio-economic disparities in health and nutritional transition in developing countries. Dr. Janjua also teaches a graduate course on epidemiologic methods at UBC School of Population and Public Health.
Yousafzai MT, Siddiqui AR, Janjua NZ. Health belief model to predict sharps injuries among health care workers at first level care facilities in rural Pakistan. Am J Ind Med. 2013 Apr;56(4):479-87. doi: 10.1002/ajim.22117.
Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, Dionne M, Sabaiduc S, Gardy JL, Li G, Bastien N, Petric M, Boivin G, Li Y. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis. 2012 Dec 15;206(12):1852-61. doi: 10.1093/infdis/jis500.
Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, Winter AL, Hottes TS, Fonseca K, Charest H, Drews SJ, Sabaiduc S, Bastien N, Li Y, Gardy JL, Petric M. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis. 2012 Jun 15;205(12):1858-68. doi: 10.1093/infdis/jis283.
Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, Petric M, Lem M, Tang P, De Serres G, Patrick DM, Bowering D. Transmission dynamics and risk factors for pandemic H1N1-related illness: outbreak investigation in a rural community of British Columbia, Canada. Influenza Other Respi Viruses. 2012 May;6(3):e54-62. doi: 10.1111/j.1750-2659.2012.00344.x.
Janjua NZ, Iqbal R, Mahmood B. Association of socioeconomic position with under- and over-nutrition in Pakistan. Ann Epidemiol. 2011 Dec;21(12):884-91. doi: 10.1016/j.annepidem.2011.08.006.
Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ. 2011 Feb 3;342:c7297. doi: 10.1136/bmj.c7297.
Janjua NZ, Hamza HB, Islam M, Tirmizi SF, Siddiqui A, Jafri W, Hamid S. Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. J Viral Hepat.2010 May;17(5):317-26. doi: 10.1111/j.1365-2893.2009.01230.x.
For full list of publications and citations in Google Scholar click here.
For publications in PubMed click here.